Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: evafenyvesi

September 29, 2023 Food / Non-pharma applications

Special Issue “New Advances in Green Extraction Technology for Natural Products”

Special Issue “New Advances in Green Extraction Technology for Natural Products” in the Open Access Journal /Processes/ (ISSN 2227-9717; indexed

Continue reading

September 28, 2023 CD as API / Drug delivery / Pharma applications

Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis

A disorder of cholesterol homeostasis is one of the main initiating factors in the progression of atherosclerosis (AS). Metabolism and

Continue reading

September 27, 2023 CD as API / Pharma applications

Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins

Despite advancements in contemporary therapies, cardiovascular disease from atherosclerosis remains a leading cause of mortality worldwide. Supported lipid bilayers (SLBs)

Continue reading

September 26, 2023 Drug delivery / Pharma applications / Uncategorized

Cytotoxicity of 5-Fluorouracil- Loaded, β-Cyclodextrin-Tethered Metallic Copper Nanoparticles on Triple-Negative Breast Cancer Cells

Metal nanoparticles represent simple nanoscale structures that can be employed in drug delivery. The complication due to multiple elements in

Continue reading

September 25, 2023 CD as API / Drug delivery / Pharma applications

Application of Cyclodextrin for Cancer Immunotherapy

Tumor immunotherapy, compared with other treatment strategies, has the notable advantage of a long-term therapeutic effect for preventing metastasis and

Continue reading

September 20, 2023 CD as API / Pharma applications

PhD and post-doctoral fellowships

Up to 12 fully funded PhD positions have been offered to highly motivated and talented researchers at the Cologne Graduate

Continue reading

September 19, 2023 Drug delivery / Pharma applications

Curcumin/amphiphilic cyclodextrin nanoassemblies: Theoretical andspectroscopic studies to address their debut in anticancer therapy

Curcumin and its derivatives have been extensively used as natural adjuvants in different pathologies including cancer, cardiovascular disease, Alzheimer’s disease,

Continue reading

September 15, 2023 Events

EuroCD2023 concluded

The 7th European Cyclodextrin Conference was held successfully on Sep. 5-8 in Budapest with 190 registered participants from 24 countries.:

Continue reading

September 13, 2023 Non-pharma applications / Other industrial use

Inclusion complexes of conducting arylidene copolymers as corrosion inhibitors for mild steel

Modifying the metal surface is one solution to the industry’s growing corrosion problem. Thus, via threading approach and insertion of

Continue reading

September 12, 2023 Drug delivery / Pharma applications

Green Synthesis of Polycyclodextrin/Drug Inclusion Complex Nanofibrous Hydrogels: pH-Dependent Release of Acyclovir

In this study, starch-derived cyclodextrin (hydroxypropyl-β-cyclodextrin (HPβCD)) was used both for forming an inclusion complex (IC) with acyclovir, a well-known

Continue reading

Posts navigation

1 2 3 … 74 Next Posts»

Recent Posts

  • Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
  • Cyclodextrin in Vaccines
  • Special Issue “New Advances in Green Extraction Technology for Natural Products”
  • Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis
  • Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins

Tags

alpha-CD Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (17)
  • Analysis (39)
  • CD as API (229)
  • CD derivatives (287)
  • Cosmetics and toilettry (22)
  • Diagnosis (2)
  • Drug delivery (499)
  • E-ducation (59)
  • Environmental (84)
  • Events (167)
  • Food (138)
  • Gene delivery (12)
  • In Hungarian (4)
  • Life sciences (21)
  • Non-pharma applications (250)
  • Other industrial use (74)
  • Pharma applications (783)
  • Supramolecular systems (30)
  • Uncategorized (56)

Top Posts

  • Cyclodextrin in Vaccines
  • BioNTech's new invention: CD as potential cryoprotectant in lipid-based RNA formulation
  • Ex Vivo Drug Screening Assay with Artificial Membranes: Characterizing Cholesterol Desorbing Competencies of Beta-Cyclodextrins
  • Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
  • Australian company pioneering Cavadextrin for regression of atherosclerosis
  • Lanosterol eye drops for cataract treatment
  • Ashland webinar — the magic rings: how cyclodextrins can enable drug development
  • How air fresheners work?
  • Curcumin/amphiphilic cyclodextrin nanoassemblies: Theoretical andspectroscopic studies to address their debut in anticancer therapy
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 565 other subscribers
 

Loading Comments...